Brent Sabatini

Director of Finance/CFO at VIR BIOTECHNOLOGY, INC.

Net worth: 677 208 $ as of 2026-08-30

52 year

Consumer Services

Health Technology

Profile

Brent Sabatini is Senior VP, Chief Financial & Accounting Officer at Vir Biotechnology, Inc. since 2026.
Formerly, Mr. Sabatini was Head-Finance at Capsida Biotherapeutics, Inc. from 2021 to 2023.
Education includes an MBA from Stephen M.
Ross School of Business and an undergraduate degree from The California State University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VIR BIOTECHNOLOGY, INC. 0.04%	2026-05-31	61,902 ( 0.04% )	677 208 $	2026-08-30

Brent Sabatini active positions

Companies	Position	Start
VIR BIOTECHNOLOGY, INC.	Director of Finance/CFO	2026-08-02

All active positions of Brent Sabatini

Former positions of Brent Sabatini

Companies	Position	End
Capsida Biotherapeutics, Inc. Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders	Corporate Officer/Principal	2023-01-31

See the detail of Brent Sabatini's experience

Training of Brent Sabatini

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brent Sabatini's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
The California State University The California State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stephen M. Ross School of Business Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vir Biotechnology, Inc. Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases	Health Technology
Capsida Biotherapeutics, Inc. Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders	Health Technology